Switch to
More onapp

Themis Medicare Ltd

THEMISMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,201 cr, stock is ranked 983
Moderate RiskStock is 2.80x as volatile as Nifty
1,305.5569.70 (+5.64%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,201 cr, stock is ranked 983
Moderate RiskStock is 2.80x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
15.37
PB RatioPB Ratio
3.90
Dividend YieldDiv. Yield
0.41%
Sector PESector PE
33.63
Sector PBSector PB
4.12
Sector Div YldSctr Div Yld
0.94%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.

Investor PresentationView older 

Nov 9, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022188.69213.96243.77412.49-10.7424.7935.7072.88
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnFeb 7, 2023

Themis Medicare Limited has informed the Exchange about Schedule of meet | Download

Themis Medicare Limited has informed the Exchange about Schedule of meet | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnFeb 6, 2023

Themis Medicare Limited has informed the Exchange about Earning Conference Call, which was scheduled on Tuesday, 7th February, 2023 at 04:30 PM has been rescheduled to Wednesday, 8th February, 2023 at 04:30 PM. | Download

Themis Medicare Limited has informed the Exchange about Earning Conference Call, which was scheduled on Tuesday, 7th February, 2023 at 04:30 PM has been rescheduled to Wednesday, 8th February, 2023 at 04:30 PM. | Download

Cash Dividend 
Ex. DateSep 8, 2022

Final • Div/Share: ₹ 5

See all events